Global Coronavirus Diagnostics Market Size study, by Type of Test (Molecular and Serology), by End-User and Regional Forecasts 2020-2026
発行: Bizwit Research & Consulting LLP
新型コロナウイルス感染症 (Covid-19) の急速な感染拡大を受けて、世界のコロナウイルス診断市場は今後急速に拡大していく、と考えられています。
当レポートでは、世界のコロナウイルス診断検査の市場について分析し、市場の基本構造 (バリューチェーンなど) や主な促進・抑制要因、全体的な市場規模の動向見通し (過去3年間・今後8年間分)、検査の種類別・エンドユーザー別および地域別の詳細動向、主要企業のプロファイル・市場シェアといった情報を取りまとめてお届けいたします。
Global Coronavirus Diagnostics Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. The emerging pandemic, novel coronavirus disease (COVID-19) is caused by SARS-COV-2 and spreads from animals to humans, and from humans to humans in general. Typically, the virus travels from the infected person's blood droplets, or the infected person's nose discharges as they cough or sneeze. First case of the disease was identified in Wuhan, China in December 2019 and since then it has spread to millions of infected areas of the world. As of 9 April 2020, the estimated number of cases of coronavirus reached 1.5 million worldwide, some 330,000 of them had survived and more than 88,000 individuals had died. A significant number of patients infected by COVID-19 reported fever and acute respiratory symptoms, according to the US Centers for Disease Control and Prevention. Findings were obtained from laboratory or clinical experiments performed on patients in the initial phase of the viral infection, centered in various countries. Specimens obtained from the blood of patients living in various regions showed a drop in the number of lymphocytes in the white blood cell count. However, the blood samples collected from critically ill patients showed a steady as well as a substantial decrease in the number of lymphocytes in the blood and an increase in the abundance of D-dimer. The diagnosis of the novel coronavirus is predictive, and for subjects diagnosed with acute coronavirus infection oxygen therapy is a key medical procedure towards the diagnosis. In addition, at the time of oxygen therapy, automatic ventilation may be used during respiratory collapse, and hemodynamic assistance is required to manage septic shock skillfully. By providing safe automatic ventilation and non-invasive ventilation or high flow nasal oxygen, respiratory failure may be treated as per WHO's guidance of 28 January 2020. The UN's public health body has approved the inoculation and consumption of Lopinavir / ritonavir alpha-interferon, or drug.
The regional analysis of Coronavirus Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America contributes substantial share of the global market and anticipated a considerable growth rate over the forecast period due to developed medical infrastructure and favorable health insurance policies in most countries in the region and the involvement of the region's leading manufacturers.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Bio-Rad Laboratories Inc.
Beckman Coulter Inc.
Becton, Dickinson and Company
GlaxoSmithKline Biologicals SA
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type of Test:
Public Health Labs
Private or Commercial Labs
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2016, 2017, 2018
Base year - 20198
Forecast period - 2020 to 2026
Target Audience of the Global Coronavirus Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers